¬Antidiabetic Activity of Ethanol Extract of Tetracera scandens (L.) Merr. Stems
Diabetes mellitus is a metabolic disorder which had a high prevalence in Indonesia. Traditional medicinal plants have been developed to treat diabetes mellitus. One of them is Tetracera scandens (L.) Merr.This study aimed to determine the antidiabetic activity of the ethanol extract of T.scandens stems on blood glucose levels, insulin levels, and homeostatic model assessment for insulin resistance (HOMA-IR) in mice induced by alloxan. Animals were grouped into five groups: normal group, negative control, and extract doses of 175, 350, and 700 mg/kg BW. Animals were induced with an alloxandose of 175 mg/kg BW. The extract was given orally for 21 days.The results showed that the administration of ethanol extract ofT.scandens stemscould significantly reduce blood glucose levels, increase insulin levels and reduce insulin resistance (p<0.05).It can be concluded that the ethanol extract of T.scandens potential to develop as herbal medicine in diabetes mellitus therapy. Further study is needed toconfirmthe antidiabetic activity of T.scandens.
2. Herningtyas EH, Ng TS. Prevalence and distribution of metabolic syndrome and its components among provinces and ethnic groups in Indonesia.BMC Public Health. 2019; 19(1):377. https://doi.org/10.1186/s12889-019-6711-7.
3. American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl. 1):S98–110. https://doi.org/10.2337/dc20-S009.
4. Kim DH, Lee S, Chung YW, Kim BM, Kim H, Kim K, Yang KM. Antiobesity and anti-diabetes effects of a Cudrania tricuspidatahydrophilic extract presenting PTP1B inhibitory potential. Biomed Res Int. 2016. https://doi.org/10.1155/2016/8462759.
5. Nokhala A and Siddiqui MJ. Phytochemicals and biological activity of Tetracera scandens Linn. Merr (Dilleniaceae): A short review. J Pharm Bioallied Sci. 2020;12(3):217–22. https://doi.org/10.4103/jpbs.JPBS_192_19.
6. Muliyah E, Sulistijorini S, Sulistyaningsih Y, Rafi M. Tetracera scandens as a medicinal plant: Secretory structures, histochemistry, and antibacterial activity. J Trop Life Sci. 2018;8(1):68–74. https://doi.org/10.11594/jtls.09.01.12.
7. Zhang CH, Xu GL, Liu YH, Rao Y, Yu RY, Zhang ZW, Wang YS, Tao L. Anti-diabetic activities of Gegen Qinlian decoction in high-fat diet combined with streptozotocin-induced diabetic rats and in 3T3-L1 adipocytes. Phytomedicine. 2013;20(3–4):221–9. https://doi.org/10.1016/j.phymed.2012.11.002
8. Ghorbani A, Rashidi R, Shafiee-Nick R. Flavonoids for preserving pancreatic beta cell survival and function: A mechanistic review. Biomed Pharmacother. 2019;111:947–57. https://doi.org/10.1016/j.biopha.2018.12.127.
9. Lee MS, Kim CH, Hoang DM, Kim BY, Sohn CB, Kim MR, Ahn JS. Genistein-derivatives from Tetracera scandens stimulate glucose uptake in L6 myotubes. Biol Pharm Bull. 2009;32(3):504–8. https://doi.org/10.1248/bpb.32.504.
10. Umar A, Ahmed QU, Muhammad BY, Dogarai BBS, Soad SZBM. Anti-hyperglycemic activity of the leaves of Tetracera scandens Linn. Merr. (Dilleniaceae) in alloxan-induced diabetic rats. J Ethnopharmacol. 2010;131(1):140–5. https://doi.org/10.1016/j.jep.2010.06.016
11. Ahmed D, Kumar V, Sharma M, Verma A. Target guided isolation, in-vitro antidiabetic, antioxidant activity and molecular docking studies of some flavonoids from Albizzia Lebbeck Benth. bark. BMC Complement Altern Med. 2014;14:155. https://doi.org/10.1186/1472-6882-14-155.
12. Banu KS, Cathrine L. General techniques involved in phytochemical analysis. Int J Adv Res Chem Sci. 2015;2(4):25–32.
13. Amini L, Mojab F, Jahanfar S, Sepidarkish M, Raoofi Z, Maleki-Hajiagha A. Efficacy of Salvia officinalis extract on the prevention of insulin resistance in euglycemic patients with polycystic ovary syndrome: A double-blinded placebo-controlled clinical trial. Complement Ther Med. 2020;48. https://doi.org/10.1016/j.ctim.2019.102245.
14. Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG. Prevalence and determinants of insulin resistance among U.S. adolescents: A population-based study. Diabetes Care. 2006;29(11):2427–32. https://doi.org/10.2337/dc06-0709.
15. Kameswara Rao B, Renuka Sudarshan P, Rajasekhar MD, Nagaraju N, Appa Rao C. Antidiabetic activity of Terminalia pallida fruit in alloxan-induced diabetic rats. J Ethnopharmacol. 2003;85(1):169–72. https://doi.org/10.1016/s0378-8741(02)00396-3.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).